<DOC>
	<DOCNO>NCT00635960</DOCNO>
	<brief_summary>Several drug propose ALS . These drug include : Topiramate , Lamotrigine , creatine , Vit . E , Pentoxifylline , etc . Although trial show positive trend , none reach statistically significant result . The exception Riluzole trial , demonstrate small significant reduction mortality treat untreated patient . Aim study determine add-on GH treatment Riluzole able reduce neuronal loss motor cortex ALS patient .</brief_summary>
	<brief_title>Growth Hormone Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Several drug propose ALS . These drug include : Topiramate , Lamotrigine , creatine , Vit . E , Pentoxifylline . Although trial show positive trend , none reach statistically significant result . The exception Riluzole trial , demonstrate small significant reduction mortality treat untreated patient . When administer SOD-1 transgenic mouse , IGF-I prolongs survival , ameliorate muscular strength , reduces weight motor neuron loss , astrocyte gliosis , ubiquitin positive protein inclusion . Two clinical trial perform ALS patient s.c. administration IGF-I indicate possible beneficial effect , third clinical trial progress . Methionyl growth hormone ( mGH ) show effect survival , disease progression muscular strength . MGH administer fix dose peripheral production IGF-I appear normal . We propose double-blind trial Growth Hormone ( GH ) add-on therapy Riluzole , individually regulate dose base peripheral response IGF-I . Aim study determine add-on GH treatment Riluzole able reduce neuronal loss motor cortex ALS patient . As secondary objective , effect GH mortality , QoL , motor function assess .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Definite/probable ALS accord El Escorial criterion Aged &gt; 40 , &lt; 85 year Progression onset Disease duration ≤3 year Treatment Riluzole Rapid disease progression first 6 month diagnosis Patients tracheostomy and/or Gastrostomy Disease duration &gt; 3 year Patient exclusive bulbar 2° motorneuron involvement Hepatic/renal failure Pregnant breastfeeding Signs active neoplasia Complicated Diabetes Severe hypertension Unable undergo MRI exam</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>ALS</keyword>
	<keyword>Growth Hormone</keyword>
	<keyword>IGF-I</keyword>
</DOC>